Metal-Complexed 1,2,4-Triazine for Fast Bioorthogonal Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bioorthogonal pretargeting methods for medical imaging and therapeutic agent delivery face challenges such as slow reaction rates and instability of reagents under physiological conditions, particularly with 1,2,4-triazine derivatives, which do not meet the required kinetic criteria for fast reactions in vivo.
Innovation Solution
Complexing 1,2,4-triazine with a metal to enhance the rate of inverse electron demand Diels-Alder/retro-Diels-Alder (IEDDA/RDA) reactions, leading to the formation of pyridine metal complexes that are more stable, soluble, and photostable, allowing for faster imaging and reduced background luminescence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If 1,2,4-triazine derivatives are used as bioorthogonal reagents, then stability under physiological conditions is improved, but reaction rate is insufficient for in vivo applications
Solution Approach 1:
The patent changes the chemical parameters of the triazine derivative by introducing metal coordination sites and modifying the electronic structure through ligand substitution. This transforms the triazine from a stable but slow-reacting reagent into a metal-complexed species that maintains stability while achieving fast reaction rates suitable for in vivo applications.
Solution Approach 2:
The patent creates composite reagents by combining metal centers with triazine ligands to form metal-complexed triazine derivatives. This composite structure leverages the stability of the triazine core while the metal coordination provides catalytic activity and enhanced reaction kinetics, resolving the contradiction between stability and reaction rate.
2Measurement precision
If pretargeting methods are used to reduce exposure time, then imaging specificity is improved, but reaction time between probes remains too long
Solution Approach 1:
The patent changes the kinetic parameters of the bioorthogonal reaction by metal coordination, increasing the rate constant from typical bioorthogonal rates (10^-2 to 10^0 M^-1s^-1) to enhanced rates that enable faster probe conjugation. This reduces the time loss between administering the first and second probes while maintaining imaging specificity.
3Speed
If conventional bioorthogonal reactions are used, then reactivity is achieved, but background luminescence interferes with imaging quality
Solution Approach 1:
The patent extracts the luminescent functionality from the background environment by using metal complexes that are dark at rest but become luminescent only upon binding to the target. This separation of states eliminates background luminescence interference while maintaining high reactivity through metal coordination.
Solution Approach 2:
The patent utilizes metal-complexed triazine derivatives that exhibit luminescence turn-on behavior, changing from non-luminescent to luminescent states upon binding to the target analyte. This dynamic optical property change eliminates background interference while maintaining high reactivity through metal coordination.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The metal-complexed triazine approach significantly increases reaction rates, improves stability and solubility, and enables luminescent probes that 'switch on' only upon binding, reducing exposure and enhancing imaging efficiency by eliminating background luminescence.
Implementation Method 1
The methods involve reacting a triazine that is complexed to a metal with a dienophile. The reactants are bioorthogonal and the methods are particularly useful in medical imaging and in delivering therapeutic agents to particular tissue or site.
Data Source
AI summary
The present invention relates to methods of forming metal-pyridine derivative complexes using pericyclic reactions with metal-1,2,4-triazine derivative complexes and a dienophile as the reactants. The reactants are bioorthogonal and the methods are particularly useful in preparing imaging agents.